CUSIP: 03842B101
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
21,415,191
-
Share change
-
-78,936
-
Total reported value
-
$301,530,377
-
Put/Call ratio
-
150%
-
Price per share
-
$14.08
-
Number of holders
-
49
-
Value change
-
-$375,535
-
Number of buys
-
27
-
Number of sells
-
21
Quarterly Holders Quick Answers
What is CUSIP 03842B101?
CUSIP 03842B101 identifies AQXP - AQUINOX PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 03842B101:
Institutional Holders of AQUINOX PHARMACEUTICALS INC - COM (AQXP) as of Q1 2018
As of 31 Mar 2018,
AQUINOX PHARMACEUTICALS INC - COM (AQXP) was held by
49 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,415,191 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, BlackRock Inc., Boxer Capital, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Ghost Tree Capital, LLC, VANGUARD GROUP INC, Alyeska Investment Group, L.P., and Point72 Asset Management, L.P..
This page lists
49
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.